Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 3/20 | 0.32 |
| ▸ | PPARA | Q07869 | 2/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | TACR1 | P25103 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22156737 | 1.00 | KIF11 (0.35) | KIF11KDM4EATML3MBTL1PPARG | |
| SCHEMBL22157338 | 0.93 | KIF11 (0.38) | KIF11KDM4EATML3MBTL1PPARG | |
| SCHEMBL22156738 | 0.93 | KIF11 (0.38) | KIF11KDM4EATML3MBTL1PPARG | |
| SCHEMBL22157352 | 0.87 | KIF11 (0.40) | KIF11PPARGPPARAHSP90AA1TACR1 | |
| SCHEMBL22157671 | 0.87 | KIF11 (0.37) | KIF11HSP90AA1TACR1TDP1 | |
| SCHEMBL22157448 | 0.87 | TACR1 (0.36) | KIF11TACR1TDP1NR3C1PGR | |
| SCHEMBL22157614 | 0.86 | KIF11 (0.38) | KIF11KDM4EATML3MBTL1PPARG | |
| SCHEMBL22157605 | 0.86 | KIF11 (0.38) | KIF11KDM4EATML3MBTL1PPARG | |
| SCHEMBL22158633 | 0.84 | KIF11 (0.36) | KIF11KDM4EATML3MBTL1PPARG | |
| SCHEMBL22156750 | 0.84 | KIF11 (0.36) | KIF11KDM4EATML3MBTL1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3635070-B1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-04-28 | — | — | EP | disclosed |
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | KIF11 4485/4885KDM4E 4239/4885ATM 4062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.